Top 20 ipsen.com competitors & alternatives
[ipsen global - a biopharmaceutical company | innovation for patient care Ipsen: a global specialty-driven biopharmaceutical group focused on innovation and specialty care. Our goal is to leave no patient behind.]
ipsen.com competitors and alternatives
Top 20 ipsen.com competitors and alternatives are ranked by similar search terms, traffic and worth.
ipsen.com's top 5 competitors are: gicasym.org with 21,500 daily traffic and 237,300 estimated worth, lexpharma.com with 145 daily traffic and 35,800 estimated worth, dysport.com with 0 daily traffic and 21,400 estimated worth, debiopharm.com with 0 daily traffic and 21,000 estimated worth, leo-pharma.com with 738 daily traffic and 16,200 estimated worth.
dysport.com
Dysport® (abobotulinumtoxinA) - Official Patient Website | Dysport
Dysport® (abobotulinumtoxinA) - Official Patient Website. See important safety information and boxed warning.
Daily Traffic: 0
Website Worth: $ 21,400
debiopharm.com
Debiopharm - We develop for patients and their quality of life
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Daily Traffic: 0
Website Worth: $ 21,000
nanets.net
NanoNet - Advanced Nanotechnology Solutions
The North American Neuroendocrine Tumor Society (NANETS) offers comprehensive, accredited medical education programs on NET disease that are developed by leading NET experts and designed exclusively for medical professionals. We also provide research grants, travel grants and education grants to young investigators doing preeminent work in the field of NET research. Visit our website to learn how you can get involved or to make a donation today!
Daily Traffic: 10
Website Worth: $ 7,600
ipsenus.com
Welcome to Ipsen US
We are a global biopharmaceutical leader dedicated to improving lives through innovative medicines in oncology, neuroscience, and rare diseases.
Daily Traffic: 0
Website Worth: $ 6,400
ipsen-pharma.de
Home - Ipsen Germany
Innovatives Pharma-Unternehmen mit dem Ziel: immer neue, effiziente therapeutische Lösungen zu entwickeln, um bisher nicht erfüllte medizinische Bedürfnisse zu stillen – zum Wohle der Patienten.
Daily Traffic: 0
Website Worth: $ 2,100
ipsen.de
Ipsen Global: Heat treatment furnaces
Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.
Daily Traffic: 0
Website Worth: $ 100
dysporthcp.com
Dysport® (abobotulinumtoxinA) - Official Website for Healthcare Professionals | Dysport
Dysport® (abobotulinumtoxinA) for U.S Healthcare Professionals - is an injection for muscle spasticity & cervical dys
Daily Traffic: 0
Website Worth: $ 0
merrimack.com
Merrimack.com - Premium Merrimack Valley Real Estate Services
Discover top real estate services in Merrimack Valley with Merrimack.com. Buy, sell, and explore properties in Merrimack and surrounding areas with our expert guidance.
Daily Traffic: 0
Website Worth: $ 0
ronnyallan.net
Ronny Allan – Living with Neuroendocrine Cancer – International Awareness of Neuroendocrine Cancer and associated issues. Supporting and helping patients and their advocates
RonnyAllan.NET - your favourite articles. Neuroendocrine Cancer
Daily Traffic: 0
Website Worth: $ 0
fondation-ipsen.org
rare disease foundation – fondation ipsen
Rare Diseases Rare but not alone Mission Accelerate rare disease diagnosis There are 7,000 rare diseases affecting 300 million people worldwide. 75% of patients are children. 1 in 2 patients do not have an accurate diagnosis. A quarter of patients wait 4 years to get a diagnosis. Our program brings together world experts to improve … Homepage Ipsen Read More »
Daily Traffic: 0
Website Worth: $ 0
cabometyxhcp.com
CABOMETYX® (cabozantinib) HCP | See Approved Indications
CABOMETYX + OPDIVO is an FDA-approved 1L aRCC treatment. As a monotherapy, CABOMETYX is also FDA-approved for 1L & 2L aRCC & post-sorafenib HCC treatment. See Important Safety Information.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like ipsen.com